medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 601

<< Back Next >>

Rev Med Cos Cen 2012; 69 (601)

Amiloidosis laringea

Kawer WA, Madrigal RL, Mata CF
Full text How to cite this article

Language: Spanish
References: 11
Page: 125-128
PDF size: 553.26 Kb.


Key words:

No keywords

ABSTRACT

Amyloidosis disease is rarely present in head and neck. The larynx is the human organ most affected, specially in the supraglotic area. Different presentations of Amyloidosis are considered between physicians, like the localization and the differential diagnosis. Finally the biopsy is the only valid method to establish the positive diagnosis. The amyloid substance is a fibrilar proteinic material that deposits in the tissues´ extracellular space, principally in ones mesoderm derivates. The etiology of amyloidosis remains unknown, and there is no definitively established link with smoking, vocal abuse, or recurrent infections. Symptoms can be presented as dysphonia, diplophonia, whisper o shortness of breath.
The most effective treatment currently available for organlimited laryngeal amyloidosis is microdirect laryngoscopy with excision.


REFERENCES

  1. Alaani A, Warfield A, Pracy J. Management of laryngeal amyloidosis. J Laryngeal Otol 2004;118:279-83. amyloidosis masquerading as a postcricoid tumour.

  2. Buxbaum J. The amyloid disease. Cecil Textbook of medicine. 1992 Schade G, Jaehne m, Hess M. Voice-improvinglaser-surgical therapy in amyloidosis of the larynx. HNO 2004;52:740-3.

  3. Chadwick M, Buckland J, Mason P, Randall C, D, Rosen M et al. Amyloidosis of the upper aerodigestive tract. Laryngoscope 2003;113:2095-101.

  4. Edmund Pribitkin, MD; Oren Friedman, MD; Brian O’Hara, MD; Mary F. Cunnane, MD; David Levi, BS; Marc Rosen, MD; William M. Keane, MD; Robert T. Sataloff, MD, DMA. Amyloidosis of the Upper Aerodigestive Tract. Laryngoscope 113: December 2003. 2095-2101

  5. F. Vázquez de la Iglesia, N. Sánchez Ferrándis, J. Rey Martínez, D. Ruba San Miguel, J. Rama López,S. Fernández González. La amiloidosis en el área otorrinolaringológica. Acta Otorrinolaringológica Esp 2006; 57: 145-148

  6. Herbert H. Dedo, MD; Krzysztof Izdebski, PhD. Laryngeal Amyloidosis in 10 Patients. Laryngoscope, 114:1742– 1746, 2004 J Laryngol Otol 2002;116:54-6. Laryngoscope 1919;29:327-30.

  7. Lester D.R. Thompson, M.D., Gregory A. Derringer, M.D., Bruce M. Wenig, M.D. . Amyloidosis of the Larynx: A Clinicopathologic Study of 11 Cases. Mod Pathol 2000;13(5):528–535

  8. Marco Algarra J. Amiloidosis de las vías aerodigestivas superiores. Anales ORL Iber-Amer XII 1985;2:117-26.

  9. New G. Amyloid tumours of the upper air passages.

  10. Pribitkin E, Friedman O, O’hara B, Cunnane M, Levi Theaker J. A rare case of dysphagia: hypopharyngeal

  11. Thomas L Kennedy, MD; Niketu M. Patel. Md. Surgical Management of localizated amyloidosis. Laryngoscope 110: June 2000. 918-923




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2012;69